FABP2 and psoriasis: Furthermore, a number of studies showed that an altered intestinal barrier was linked with psoriasis activity and severity through quantifying intestinal barrier integrity markers (such as claudin-3 and intestinal fatty acid binding protein, I-FABP) or the serum concentrations of gut microbiota-associated metabolite trimethylamine N-oxide (TMAO) [73,74,75,76,77].